Latest News

May e-Newsletter | Celebrate & Share During National Women’s Health Week

Join the National Blood Clot Alliance (NBCA) during National Women’s Health Week (NWHW), May 13-19, 2018, as we work with the Alexandra L. Rowan Memorial Foundation to provide women with life-saving information about birth control and blood clots, and to help them determine, along with their doctor, their risk for blood clots and their best birth control…

Celebrate & Share During National Women’s Health Week

Birth Control and Blood Clots: Know Your Risk There are more than 60 million women of child-bearing age in the United States, and the majority of them report using some form of birth control. In fact, the birth control pill is their number one choice. While research shows that the birth control pill is safe and…

FDA Approves Andexxa®

NEW DRUG APPROVAL: The U.S. Food & Drug Administration (FDA) has granted Portola Pharmaceuticals approval to market Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], the first and only antidote indicated to reverse the anticoagulation effects of factor Xa inhibitors, such as Xarelto® (rivaroxaban) and Eliquis® (apixaban), when patients are experiencing uncontrolled or life-threatening bleeding. This is…

New Thrombophilia Resource

NBCA recently updated information on its website about thrombophilia or genetic blood clotting disorders, thanks to funding provided by Grifols USA. This resource provides an overview of thrombophilia and its many forms, discusses the risks and potential complications, summarizes the current perspectives about testing and diagnosis, and provides an overview of potential treatment options and…

Upcoming Events

Follow Us On Twitter